Trade AUTL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Autolus Therapeutics plc American Depositary Share (AUTL) is trading at US$1.81, up 2.26% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$641.45M. Over the past 52 weeks, AUTL has traded between US$1.18 and US$2.58. On Syfe you can trade AUTL with $0 commission and add it to your watchlist.
| Previous close | US$1.77 |
|---|---|
| Market cap | US$641.45M |
| 52-week range | US$1.18 – US$2.58 |
| Volume | 1.47M |
| Exchange | US |
Autolus Therapeutics plc American Depositary Share
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Year: 2018
Autolus Receives FDA Regenerative Medicine Advanced Therapy Designation for Obecabtagene Autoleucel
Sep 9, 11:42 AM · MT Newswires
Stay on top of AUTL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
